Sarkaria JN - Search Results

1

Mechanisms of chemoresistance to alkylating agents in malignant glioma.

Sarkaria JN, Kitange GJ, James CD, Plummer R, Calvert H, Weller M, Wick W. Sarkaria JN, et al. Clin Cancer Res. 2008 May 15;14(10):2900-8. doi: 10.1158/1078-0432.CCR-07-1719. Clin Cancer Res. 2008. PMID: 18483356 Free PMC article. Review.

2

Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.

Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT. Sarkaria JN, et al. Cancer Res. 1999 Sep 1;59(17):4375-82. Cancer Res. 1999. PMID: 10485486

3

The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.

Busby EC, Leistritz DF, Abraham RT, Karnitz LM, Sarkaria JN. Busby EC, et al. Among authors: sarkaria jn. Cancer Res. 2000 Apr 15;60(8):2108-12. Cancer Res. 2000. PMID: 10786669

4

Combination of epidermal growth factor receptor targeted therapy with radiation therapy for malignant gliomas.

Krishnan S, Rao RD, James CD, Sarkaria JN. Krishnan S, et al. Among authors: sarkaria jn. Front Biosci. 2003 Jan 1;8:e1-13. doi: 10.2741/895. Front Biosci. 2003. PMID: 12456322 Review.

5

Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL, Schroeder MA, James CD. Giannini C, et al. Among authors: sarkaria jn. Neuro Oncol. 2005 Apr;7(2):164-76. doi: 10.1215/S1152851704000821. Neuro Oncol. 2005. PMID: 15831234 Free PMC article.

6

Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells.

Rao RD, Mladek AC, Lamont JD, Goble JM, Erlichman C, James CD, Sarkaria JN. Rao RD, et al. Among authors: sarkaria jn. Neoplasia. 2005 Oct;7(10):921-9. doi: 10.1593/neo.05361. Neoplasia. 2005. PMID: 16242075 Free PMC article.

7

Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.

Sarkaria JN, Carlson BL, Schroeder MA, Grogan P, Brown PD, Giannini C, Ballman KV, Kitange GJ, Guha A, Pandita A, James CD. Sarkaria JN, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2264-71. doi: 10.1158/1078-0432.CCR-05-2510. Clin Cancer Res. 2006. PMID: 16609043

8

Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel.

Sarkaria JN, Yang L, Grogan PT, Kitange GJ, Carlson BL, Schroeder MA, Galanis E, Giannini C, Wu W, Dinca EB, James CD. Sarkaria JN, et al. Mol Cancer Ther. 2007 Mar;6(3):1167-74. doi: 10.1158/1535-7163.MCT-06-0691. Mol Cancer Ther. 2007. PMID: 17363510

9

Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy.

Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, Gupta N, Berger MS, James CD. Dinca EB, et al. Among authors: sarkaria jn. J Neurosurg. 2007 Sep;107(3):610-6. doi: 10.3171/JNS-07/09/0610. J Neurosurg. 2007. PMID: 17886562

10

Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.

Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E. Liu C, et al. Among authors: sarkaria jn. Clin Cancer Res. 2007 Dec 1;13(23):7155-65. doi: 10.1158/1078-0432.CCR-07-1306. Clin Cancer Res. 2007. PMID: 18056196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters